deemed to be too hazardous after ten days, in spite of marked symptomatic improvement. Azathioprine was therefore stopped and orthodox high dosage steroid therapy substituted. After three weeks, progress was so unsatisfactory that azathioprine was added and the steroids rapidly reduced. There was rapid improvement and complete healing occurred on azathioprine alone.
Three of the series were failed steroid cases, and on moderate local or systemic steroid dosage remission could not be achieved. Azathioprine in full dosage was then added and, after improvement occurred, the steroid dose was rapidly reduced in all except one, who had had continuous steroid therapy for five years without remission. In all 3 cases, complete remission symptomatically and sigmoidoscopically was achieved and maintained on azathioprine alone.
Two post-operative cases have been treated. In one, with a severe proctitis complicating ileorectal anastomosis, complete control was obtained but he remains on treatment, and the two days when off azathioprine are covered by prednisone. In the other, a severe chronic proctitis of seven years' duration in a large isolated rectal stump, the response has been disappointing, with little apart from symptomatic improvement. In this case, however, severe fibrosis and shrinkage of the organ has occurred and it measures only lOxS 15 cm.
Dr E Mary Cooke (St Bartholomew's Hospital, London)
Escherichia coli and Ulcerative Colitis Because the lesions of ulcerative colitis are in close contact with very large numbers of microorganisms, the possible role of these in initiating or exacerbating the disease has aroused considerable interest. However, investigations of this disease have generally failed to demonstrate that bacteria are of importance in the pathogenesis of ulcerative colitis (Weinstein 1961) .
I have compared quantitatively the fmcal flora of 20 patients suffering from an attack of ulcera-tive colitis with that of 20 normal persons. The organisms looked for were principally coliforms, lactobacilli, streptococci and bacteroides. The viable counts of these organisms were similar in both groups of people, but the viable counts of enterococci were slightly higher in the faces of ulcerative colitis patients and they were isolated from a higher number of these patients than from normal people (Cooke 1967) .
I also examined one group of organisms, the Escherichia coli, in detail. The coliforms were isolated from the fices of 50 patients during an attack of ulcerative colitis, from 50 normal people and from 50 people with acute diarrhcea. The properties studied were: (1) Hemolysin production.
(2) Necrotoxin production: this was tested by intradermal injection in rabbits. (3) Serotype: antisera to 'O' groups 1, 2, 4, 5, 6, 7, 8, 9, 11, 18, 39 and 75 were prepared and the E. coli were typed using these antisera. (4) Effect on ligated rabbit ileal segments.
It is known that enteropathogenic E. coli produce a positive reaction in this test (Taylor et al. 1958) . In this work, two types of positive reaction were obtained, a hemorrhagic response and a polymorphonuclear one.
Results
The results obtained are shown in Table 1 .
More of the strains from ulcerative colitis patients produced hamolysin, necrotoxin and were 'O' typable with the small numbers of antisera used than were strains from other sources. Five of the 20 ulcerative colitis strains gave a positive reaction in ligated rabbit ileal segments and one of 15 normal strains gave a positive reaction in this test (Cooke 1968) . It has been suggested by previous workers that the strains of Escherichia coli in pathological material differ from those found in the faces of normal people. This has been suggested in the case of peritonitis, appendicitis and urinary tract infections. In the case of urinary tract infection the pathogenicity of the infecting strain of Escherichia coli is clear. It is very much less so in ulcerative colitis. There appears, however, to be a possibility that these strains of Escherichia coli Medical treatment has two objectives. First, any *attacks must be checked as quickly as possible. Secondly, any measures which minimize the chance of recurrences should be employed.
Checking an Attack A severe attack of ulcerative colitis demands treatment in hospital. Certain general medical measures are of great importance in combating some of the harmful effects of the disease. They consist of the correction of dehydration and electrolyte depletion by intravenous infusion, blood transfusion to treat aneemia and a nutritious high-protein diet to minimize wasting.
Two types of therapeutic agent have been shown by controlled therapeutic trials to increase the chance of rapid remission of the attack. They are the corticosteroids and sulphasalazine (Salazopyrin).
Corticosteroids can be used in two ways. They may either be given by mouth or parenterally for their systemic action or they can be employed locally within the colon by rectal drip or retention enema. They are most efficient when these two methods of application are combined. This combined corticosteroid treatment has been shown to be more effective than sulphasalazine in checking an attack of ulcerative colitis but there is no objection to using the corticosteroids and sulphasalazine in combination and this commonly appears to be beneficial.
Mild attacks of the disease can be treated on an outpatient basis by using one, or a combination, of the three forms of medical treatment just mentioned. The importance of rapid institution of medical treatment at the first sign of relapse can hardly be emphasized too much.
Preventing Relapses
Maintenance treatment with corticosteroids in doses small enough to be reasonably safe are valueless in preventing relapse. Sulphasalazine has been shown to reduce the relapse rate when given in a dose of 05 g four times a day over the course of one year. In routine use there is no objection to continuing a maintenance dose for longer periods if there are no side-effects.
Immunosuppressive Drugs
The demonstration of autoimmune phenomena in ulcerative colitis has prompted the use of immunosuppressive drugs by a few physicians. There are several small series claiming favourable results. Marrow depression is common and a fatal case has been reported. No controlled therapeutic trials have yet been carried out and it remains doubtful if the benefits of this therapy outweigh its risks.
Exclusion Diets
The American physician, Andresen, was the first to suggest that ulcerative colitis might be due to food allergy. After prolonged study he claimed that at least two-thirds of 50 patients with ulcerative colitis were examples of food allergy, cow's milk being the food most frequently responsible. Recent work has revived interest in this possibility. A minority of patients with ulcerative colitis havw been found to benefit by rigid exclusion of milk and milk products from the diet and this has been confirmed by a controlled therapeutic trial. However, simultaneous immunological observations on reactions to the principal proteins of cow's milk failed to show any meaningful correlations with the clinical response. There is also another reason for doubting if the beneficial effect of a milk-free diet in a minority of the patients is related to immunological responses. Deficiency of small-intestine disaccharidases, especially lactase, has been found to occur not infrequently in a number of intestinal diseases including ulcerative colitis. It has been suggested that lactase deficiency could favour the colonization of the large intestine by lactosedependent organisms and that this might have a harmful effect upon the course of colitis. The few systematic studies of lactase deficiency which have so far been made in ulcerative colitis have failed to allow a decisive conclusion to be drawn; further research is required.
The following paper was also read:
Pathological Changes in the Liver in Ulcerative Colitis Dr P J Scheuer (Royal Free Hospital, London) 
